Eupraxia Pharmaceuticals EPRX
NASDAQ EPRX
$7.83 -1.27 (-13.96%)
At close: Oct 1, 2026 · 4:00 PM EDT

Eupraxia Pharmaceuticals (EPRX) Beginning Cash Balance (2023 - 2026)

Updated

Eupraxia Pharmaceuticals' Beginning Cash Balance came in at $80.56 million for the quarter ended Mar 31, 2026, up 143.4% from $33.1 million a year earlier.

Analysis

Eupraxia Pharmaceuticals (EPRX) Beginning Cash Balance (2023 - 2026) Analysis & Trends

For the year ended Dec 31, 2023, Eupraxia Pharmaceuticals' Beginning Cash Balance was $18.26 million, up 45.8% from the prior year.

  • Going back by year, Beginning Cash Balance was $12.53 million in the year ended Dec 31, 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Eupraxia Pharmaceuticals 363.60 Mn 362.00 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 80.56 Mn
Mar 31, 2025 33.10 Mn
Mar 31, 2024 19.34 Mn
Jun 30, 2023 -8.00
Mar 31, 2023 18.26 Mn
API Access

Eupraxia Pharmaceuticals Beginning Cash Balance API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=beginning-cash-balance&ticker=EPRX&period=max&api_key=YOUR_API_KEY